The Ah receptor in stem cell cycling, regulation, and quiescence
暂无分享,去创建一个
[1] S. Welle,et al. Loss of aryl hydrocarbon receptor promotes gene changes associated with premature hematopoietic stem cell exhaustion and development of a myeloproliferative disorder in aging mice. , 2014, Stem cells and development.
[2] F. Quintana,et al. Aryl Hydrocarbon Receptor Control of Adaptive Immunity , 2013, Pharmacological Reviews.
[3] Nan Hao,et al. The emerging roles of AhR in physiology and immunity. , 2013, Biochemical pharmacology.
[4] A. Regev,et al. Transcriptome Analysis Identifies Regulators of Hematopoietic Stem and Progenitor Cells , 2013, Stem cell reports.
[5] G. Pei,et al. Activation of Aryl Hydrocarbon Receptor (AhR) by Tranilast, an Anti-allergy Drug, Promotes miR-302 Expression and Cell Reprogramming* , 2013, The Journal of Biological Chemistry.
[6] B. Baban,et al. Aryl hydrocarbon receptor agonist, leflunomide, protects the ischemic-reperfused kidney: role of Tregs and stem cells. , 2012, American journal of physiology. Regulatory, integrative and comparative physiology.
[7] G. van Zant,et al. Concise Review: Hematopoietic Stem Cell Aging, Life Span, and Transplantation , 2012, Stem cells translational medicine.
[8] T. Macdonald,et al. The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis , 2012, Current opinion in gastroenterology.
[9] E. Papoutsakis,et al. The Evolving Role of the Aryl Hydrocarbon Receptor (AHR) in the Normophysiology of Hematopoiesis , 2012, Stem Cell Reviews and Reports.
[10] D. Hinds,et al. Current Status of the Epidemiologic Evidence Linking Polychlorinated Biphenyls and Non-Hodgkin Lymphoma, and the Role of Immune Dysregulation , 2012, Environmental health perspectives.
[11] R. Fry,et al. The Aryl Hydrocarbon Receptor Pathway: A Key Component of the microRNA-Mediated AML Signalisome , 2012, International journal of environmental research and public health.
[12] R. Humphries,et al. Concise Review: Multidimensional Regulation of the Hematopoietic Stem Cell State , 2012, Stem cells.
[13] Bin Zhao,et al. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[14] T. Gasiewicz,et al. Aryl Hydrocarbon Receptor Activation in Hematopoietic Stem/Progenitor Cells Alters Cell Function and Pathway-Specific Gene Modulation Reflecting Changes in Cellular Trafficking and Migration , 2011, Molecular Pharmacology.
[15] June Li. Quiescence regulators for hematopoietic stem cell. , 2011, Experimental hematology.
[16] T. Gasiewicz,et al. Aryl hydrocarbon receptor-null allele mice have hematopoietic stem/progenitor cells with abnormal characteristics and functions. , 2011, Stem cells and development.
[17] D. Shepherd,et al. Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[18] Hui-yuan Shao,et al. Nucleophosmin gene mutations promote NIH3T3 cell migration and invasion through CXCR4 and MMPs. , 2011, Experimental and molecular pathology.
[19] Anthony E. Boitano,et al. Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells , 2010, Science.
[20] S. Jackson,et al. Human SIRT6 Promotes DNA End Resection Through CtIP Deacetylation , 2010, Science.
[21] Juan Ma,et al. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. , 2010, Investigative ophthalmology & visual science.
[22] N. Kerkvliet,et al. Dioxin and immune regulation , 2010, Annals of the New York Academy of Sciences.
[23] G. Huls,et al. Paradoxical down-regulation of p16INK4a mRNA with advancing age in Acute Myeloid Leukemia , 2009, Aging.
[24] S. Swain,et al. Age-associated declines in immune system development and function: causes, consequences, and reversal. , 2009, Current opinion in immunology.
[25] G. van Zant,et al. Effects of aging on hematopoietic stem and progenitor cells. , 2009, Current opinion in immunology.
[26] D. Allman. Faculty Opinions recommendation of Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. , 2009 .
[27] Motomi Osato,et al. Stem cell exhaustion and leukemogenesis , 2009, Journal of cellular biochemistry.
[28] C. Esser. The immune phenotype of AhR null mouse mutants: not a simple mirror of xenobiotic receptor over-activation. , 2009, Biochemical pharmacology.
[29] Y. Hirabayashi,et al. Aryl hydrocarbon receptor biology and xenobiotic responses in hematopoietic progenitor cells. , 2009, Biochemical pharmacology.
[30] N. Kerkvliet. AHR-mediated immunomodulation: the role of altered gene transcription. , 2009, Biochemical pharmacology.
[31] Andreas Trumpp,et al. Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair , 2008, Cell.
[32] O. Witte,et al. Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and Arf. , 2008, Genes & development.
[33] J. Gaudet,et al. Leukemia and hematopoietic stem cells: Balancing proliferation and quiescence , 2008, Cell cycle.
[34] I. Weissman,et al. Stems Cells and the Pathways to Aging and Cancer , 2008, Cell.
[35] D. Scadden,et al. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation , 2008, Nature Reviews Genetics.
[36] T. Gasiewicz,et al. The Aryl Hydrocarbon Receptor Agonist 2,3,7,8-Tetrachlorodibenzo-p-dioxin Alters the Circadian Rhythms, Quiescence, and Expression of Clock Genes in Murine Hematopoietic Stem and Progenitor Cells , 2006, Molecular Pharmacology.
[37] M. Fraga,et al. The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding. , 2006, Carcinogenesis.
[38] C. Shaw,et al. Molecular Signatures of Proliferation and Quiescence in Hematopoietic Stem Cells , 2004, PLoS biology.
[39] S. Gaskell,et al. Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility. , 2004, Blood.
[40] T. Kajiume,et al. TCDD treatment eliminates the long-term reconstitution activity of hematopoietic stem cells. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[41] M. Tomonaga,et al. Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL. , 2003, Biochemical and biophysical research communications.
[42] C Zocchetti,et al. Health effects of dioxin exposure: a 20-year mortality study. , 2001, American journal of epidemiology.
[43] J. Viel,et al. Soft-tissue sarcoma and non-Hodgkin's lymphoma clusters around a municipal solid waste incinerator with high dioxin emission levels. , 2000, American journal of epidemiology.
[44] J. E. Staples,et al. The aryl hydrocarbon receptor has a role in the in vivo maturation of murine bone marrow B lymphocytes and their response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 2000, Toxicology and applied pharmacology.
[45] T. Gasiewicz,et al. Hemopoietic progenitor cells are sensitive targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J mice. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[46] J. E. Staples,et al. Thymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells. , 1998, Journal of immunology.
[47] J. Sundberg,et al. Lesions of Aryl-hydrocarbon Receptor–deficient Mice , 1997, Veterinary pathology.
[48] Kenji Nakamura,et al. Loss of teratogenic response to 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin (TCDD) in mice lacking the Ah (dioxin) receptor , 1997, Genes to cells : devoted to molecular & cellular mechanisms.
[49] J. Reddy,et al. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[50] T. Gasiewicz,et al. Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1990, Journal of immunology.
[51] S. Gaskell,et al. reveals differences in expression of proteins regulating motility Comparative proteomics of primitive hematopoietic cell populations , 2013 .
[52] T. Gasiewicz,et al. Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells. , 2009, Carcinogenesis.
[53] Steven Henikoff,et al. Nucleosome destabilization in the epigenetic regulation of gene expression , 2008, Nature Reviews Genetics.
[54] M. Wright. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. , 1996, Human & experimental toxicology.
[55] A Poland,et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.